- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enlivex Therapeutics Ltd (ENLV)"Enlivex Therapeutics Ltd stock price live, this page displays TASE ENLV stock exchange data. View the ENLV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Enlivex Therapeutics Ltd real time stock price chart below.
What Is the Enlivex Therapeutics Ltd Stock Price Today?
The Enlivex Therapeutics Ltd stock price today is 453.
What Is the Stock Symbol for Enlivex Therapeutics Ltd?
The stock symbol for Enlivex Therapeutics Ltd is ""ENLV.""
What Stock Exchange Does Enlivex Therapeutics Ltd Trade On?
Enlivex Therapeutics Ltd is listed and trades on the Tel Aviv stock exchange.
Is Enlivex Therapeutics Ltd a Good Stock to Buy?
Determining whether Enlivex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENLV quote. (ISIN: IL0011319527)"
What Is the Enlivex Therapeutics Ltd Stock Price Today?
The Enlivex Therapeutics Ltd stock price today is 453.
What Is the Stock Symbol for Enlivex Therapeutics Ltd?
The stock symbol for Enlivex Therapeutics Ltd is ""ENLV.""
What Stock Exchange Does Enlivex Therapeutics Ltd Trade On?
Enlivex Therapeutics Ltd is listed and trades on the Tel Aviv stock exchange.
Is Enlivex Therapeutics Ltd a Good Stock to Buy?
Determining whether Enlivex Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENLV quote. (ISIN: IL0011319527)"
453
+2(+0.44%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
439
468
52 wk Range
350
1,600
ENLV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
439468
52 wk Range
3501,600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ENLV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Enlivex Therapeutics Ltd Company Profile
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.
Compare ENLV to Peers and Sector
Metrics to compare | ENLV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENLVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −2.7x | −0.6x | |
PEG Ratio | −0.04 | −0.06 | 0.00 | |
Price/Book | 1.1x | 2.0x | 2.6x | |
Price / LTM Sales | - | 826.3x | 3.2x | |
Upside (Analyst Target) | - | 408.5% | 46.2% | |
Fair Value Upside | Unlock | −8.8% | 7.0% | Unlock |
People Also Watch
FAQ
What Is the Enlivex (ENLV) Stock Price Today?
The Enlivex stock price today is 453.00
What Stock Exchange Does Enlivex Trade On?
Enlivex is listed and trades on the Tel Aviv stock exchange.
What Is the Stock Symbol for Enlivex?
The stock symbol for Enlivex is "ENLV."
What Is the Enlivex Market Cap?
As of today, Enlivex market cap is 101.07M.
What is Enlivex Earnings Per Share?
The Enlivex EPS is -0.969.
From a Technical Analysis Perspective, Is ENLV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.